174 related articles for article (PubMed ID: 37840126)
1. Use of levosimendan in hemodynamic management of heart failure in two neonates with intracranial arteriovenous shunts: a case series.
Landolfo F; Giliberti P; De Rose DU; Pugnaloni F; Santisi A; Columbo C; Martini L; Ronchetti MP; Di Chiara L; Toscano A; Gandolfo C; Dotta A; Capolupo I
Ital J Pediatr; 2023 Oct; 49(1):141. PubMed ID: 37840126
[TBL] [Abstract][Full Text] [Related]
2. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Cavusoglu Y
Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
Udvary E; Papp JG; Végh A
Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
Lehtonen L
Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898
[TBL] [Abstract][Full Text] [Related]
5. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
Antila S; Eha J; Heinpalu M; Lehtonen L; Loogna I; Mesikepp A; Planken U; Sandell EP
Eur J Clin Pharmacol; 1996; 49(6):451-8. PubMed ID: 8706769
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
Kivikko M; Lehtonen L
Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan: a novel agent in heart failure.
Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
[TBL] [Abstract][Full Text] [Related]
10. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure.
Malfatto G; Della Rosa F; Rella V; Villani A; Branzi G; Blengino S; Giglio A; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):322-30. PubMed ID: 24699010
[TBL] [Abstract][Full Text] [Related]
12. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan: from basic science to clinical practice.
Parissis JT; Rafouli-Stergiou P; Paraskevaidis I; Mebazaa A
Heart Fail Rev; 2009 Dec; 14(4):265-75. PubMed ID: 19101796
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan: a new era for inodilator therapy for heart failure?
Cleland JG; McGowan J
Curr Opin Cardiol; 2002 May; 17(3):257-65. PubMed ID: 12015475
[TBL] [Abstract][Full Text] [Related]
16. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan in cardiac failure after subarachnoid hemorrhage.
Busani S; Rinaldi L; Severino C; Cobelli M; Pasetto A; Girardis M
J Trauma; 2010 May; 68(5):E108-10. PubMed ID: 20453750
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
Schroeder L; Holcher S; Leyens J; Geipel A; Strizek B; Dresbach T; Mueller A; Kipfmueller F
Eur J Pediatr; 2023 Jul; 182(7):3165-3174. PubMed ID: 37100959
[TBL] [Abstract][Full Text] [Related]
19. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure?
Goyer I; Brossier D; Toledano B
Arch Pediatr; 2018 Feb; 25(2):132-135. PubMed ID: 29395891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
